Portfolio Update

RNS Number : 5269S

Intl. Biotechnology Trust PLC

19 May 2009

 

INTERNATIONAL BIOTECHNOLOGY TRUST PLC    

Portfolio update as at 30 April 2009                    

Total Net Assets	£91.1m
NAV per share	140.6p
Share Price	112.5p
Total value of unquoted investments	£23.4m
Total number of portfolio companies	62
Cash	2%
Cash committed and reserved to unquoted investments	14%
Portfolio companies with < 1 year of cash	18%

Top Ten Holdings

Company Name	% NAV	Market Value
Micromet	5.9	5,385,896
Gilead Sciences	5.0	4,512,266
Celgene	5.0	4,506,486
Oxagen	4.5	4,113,978
Amgen	4.5	4,064,919
Affymax	3.1	2,800,711
Celera	3.0	2,683,949
Wright Medical	2.9	2,682,735
Alexion Pharmaceuticals	2.9	2,669,112
Halozyme Therapeutics	2.9	2,634,861
	-----------	-----------
Total	39.7	36,054,913

Geographical Allocation	% NAV
United States	81
Europe	16
Australia	1
Cash	2
	-----------
Total	100

Quoted/Unquoted allocation	% NAV
Quoted	72
Unquoted	26
Cash	2
	-----------
	100

BNP Paribas Secretarial Services Limited

Company Secretary

19 MAY 2009

 

END

 

 

PFUBUGDUSSBGGCC